REIN THERAPEUTICS INC (RNTX:NASDAQ)
$1.76 0.06 (3.5294%)
Analysed REIN THERAPEUTICS INC (RNTX:NASDAQ) News Sources
Rein Therapeutics Doses First Patient in Phase 2 Trial of LTI-03 for Idiopathic Pulmonary Fibrosis
03-03-2026
yahoo.com
Rein Therapeutics Receives Orphan Drug Designation from European Medicines Agency for Lead Drug Candidate in Idiopathic Pulmonary Fibrosis
20-01-2026
yahoo.com
Rein Therapeutics Announces New Scientific Publication Demonstrating LTI-03 May Reduce Lung Scarring and Protect Cells Needed for Lung Repair in IPF
06-11-2025
yahoo.com
Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
03-11-2025
yahoo.com
Rein Therapeutics Receives European Regulatory Approval to Initiate Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
09-10-2025
yahoo.com
Rein Therapeutics Announces Publication of New Translational Data in iScience on Company’s Novel Therapy for Idiopathic Pulmonary Fibrosis
17-09-2025
yahoo.com
Palo Alto upgraded, Li Auto downgraded: Wall Street's top analyst calls
19-08-2025
yahoo.com
Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
19-08-2025
yahoo.com
Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025
14-08-2025
yahoo.com
Rein Therapeutics Enters into Agreements for up to $21 Million in Flexible Financing
30-07-2025
yahoo.com
What is the current price of REIN THERAPEUTICS INC (RNTX:NASDAQ)?
The current price of REIN THERAPEUTICS INC (RNTX:NASDAQ) is $1.76.
REIN THERAPEUTICS INC (RNTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of REIN THERAPEUTICS INC (RNTX:NASDAQ) since the previous trading day is $0.06.
REIN THERAPEUTICS INC (RNTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of REIN THERAPEUTICS INC (RNTX:NASDAQ) since the previous trading day is 3.5294%.
What is the most recent average sentiment score for REIN THERAPEUTICS INC (RNTX:NASDAQ)?
The most recent average sentiment score for REIN THERAPEUTICS INC (RNTX:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for REIN THERAPEUTICS INC (RNTX:NASDAQ)?
The most recent sentiment for REIN THERAPEUTICS INC (RNTX:NASDAQ) is .
SEC-8K** Filing Available For REIN THERAPEUTICS INC (RNTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.